全神貫注的合資企業

2023年5月29日

紐約初創公司百思,換來了3美元的種子資金輪由先鋒基金。這注資還有一個重大投資等從Y Combinator和其他著名的投資者7 g Bioventures和投注的合資企業。百思也吸引Y Combinator校友的注意,獲得超過500美元的任務將母乳存儲和管理在醫院。“幾十年來醫院已經花了一些有限的護理資源的管理和除霜珍貴捐贈者乳房牛奶是非常脆弱的,需要特殊雖說它不會毀了,毀了,”蘭格Vansh博士說,百思CEO。“除霜過程是一項乏味且長達數小時的過程;實際上一個NICU護士每天隻是工作的監督。我們的使命是為醫院提供shelf-stabilized和凝聚母乳容易存儲和重建,所以護士可以把他們的技能重要和關鍵的嬰兒護理。”“這對醫院科技是一個改變遊戲規則。臨床資料證實,這些嬰兒的營養是一樣好,容易消化母乳,從未凝聚,”博士說布蘭卡Aguilar Uscanga,作用的科學。“我們的驕傲地過程保持母乳,母乳。沒有添加,刪除。” The United States spends an estimated $12 billion annually on the procurement and management of breast milk. Costs per ounce range from $9 to $15, making it a significant expense for healthcare providers. This is the gap BBy seeks to bridge, offering a shelf-stable solution for breast milk that has the potential to save hospitals millions of dollars monthly in labor costs. Since its inception in 2017 by Vansh Langer, BBy has been committed to providing an innovative alternative to a 70-year-old process that requires freezing and long defrosting times for donor milk. By eliminating extensive manual handling and the need for specialized storage facilities, hospitals can repurpose resources and focus on critical patient care. BBy’s innovative process transforms breast milk into powder without losing essential nutrients. This is achieved using a unique system that employs a computer program and laser technology to monitor the weight and temperature of the milk during the drying process, ensuring vital substances are preserved. Packaged into convenient aluminum packets, this condensed breast milk is delivered bi-weekly to Neonatal Intensive Care Units (NICUs). Nurses can easily reconstitute the milk with water, utilizing only the required amount, thus reducing waste. BBy has successfully implemented this technology in eight regional processing facilities close to its partner hospitals. BBy’s state-of-the-art two-factor laser works in tandem with commercial condensers to constantly monitor and adjust the weight and temperature of the breast milk during processing. This maintains the milk in the bioactive zone, resulting in a shelf-stabilized powder that retains all its nutritional and immunological properties. The company’s approach is already in use at leading research hospitals in Massachusetts, Connecticut, and Texas. Each facility processes ten gallons of breast milk twice daily, with the resultant condensed milk having a safe shelf-life of up to six months. With this recent funding, BBy aims to expand its transformative solution to hospitals nationwide. You May Also Like